Supplement: VA HB1187 | 2024 | Regular Session | House: Impact statement from DPB (HB1187H1)

For additional supplements on Virginia HB1187 please see the Bill Drafting List
Bill Title: Xylazine; penalty for manufacturing, selling, etc., for human consumption.

Status: 2024-04-04 - Governor: Acts of Assembly Chapter text (CHAP0472) [HB1187 Detail]

Download: Virginia-2024-HB1187-House_Impact_statement_from_DPB_HB1187H1_.pdf
It appears your computer is unable to display this document, however you can Download Virginia-2024-HB1187-House_Impact_statement_from_DPB_HB1187H1_.pdf here.
feedback